Tech Center 1600 • Art Units: 1633
This examiner grants 63% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17273999 | NUCLEIC ACID ASSEMBLIES FOR USE IN TARGETED DELIVERY | Final Rejection | Massachusetts Institute of Technology |
| 17593085 | METHODS FOR PRODUCTION OF CAR-NK CELLS AND USE THEREOF | Non-Final OA | Board of Regents, The University of Texas System |
| 18015158 | Improving Packed Red Blood Cell Storage with a High Viscosity Buffered Storage Solution | Non-Final OA | University of Cincinnati |
| 19017125 | MESENCHYMAL STROMAL CELL-DERIVED EXTRACELLULAR VESICLE-EXOSOMES | Final Rejection | Biotech Therapeutics, LLC |
| 17430541 | COMPOSITIONS AND METHODS FOR STEM CELL THERAPY | Non-Final OA | University of Houston System |
| 17271902 | METHOD FOR EVALUATING ANTI-INFECTIVE DRUGS, VACCINES, ETC. USING IMMORTALIZED MONOCYTIC CELLS AND INDUCED CELLS | Final Rejection | OSAKA UNIVERSITY |
| 18037945 | LIGHT-CONTROLLED VIRAL TRANSDUCTION | Non-Final OA | ALBERT-LUDWIGS-UNIVERSITÄT FREIBURG |
| 18569736 | METHOD FOR PRODUCING CEREBRAL CORTICAL CELL PREPARATION DERIVED FROM HUMAN PLURIPOTENT STEM CELLS | Non-Final OA | RACTHERA Co., Ltd. |
| 17738584 | INDUCTION OF TUMOR VASCULAR NECROSIS UTILIZING FIBROBLASTS | Non-Final OA | FibroBiologics |
| 17603276 | Systems, Methods And Compositions For Recombinant In Vitro Transcription And Translation Utilizing Thermophilic Proteins | Final Rejection | Nature's Toolbox, Inc. |
| 17761565 | BONE MARROW MESENCHYMAL STEM CELL DERIVED CELL POPULATIONS AND METHODS OF PREPARING SAME | Final Rejection | THE UNIVERSITY OF LIVERPOOL |
| 18028029 | VIRAL VECTORS AND USES THEREOF | Non-Final OA | SUNSHINE LAKE PHARMA CO., LTD. |
| 17293797 | FUSOSOME COMPOSITIONS FOR HEMATOPOIETIC STEM CELL DELIVERY | Non-Final OA | FLAGSHIP PIONEERING INNOVATIONS V, INC. |
| 17781843 | Methods of Decellularization and Recellularization of Organs and Portions of Organs | Final Rejection | Miromatrix Medical Inc. |
| 17312783 | METHODS OF MANUFACTURING CELL BASED PRODUCTS USING SMALL VOLUME PERFUSION PROCESSES | Non-Final OA | ERBI BIOSYSTEMS, INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy